These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26223359)

  • 1. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.
    Romano A; Parrinello NL; Consoli ML; Marchionni L; Forte S; Conticello C; Pompa A; Corso A; Milone G; Di Raimondo F; Borrello I
    Ann Hematol; 2015 Nov; 94(11):1875-83. PubMed ID: 26223359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
    Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
    Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Neutrophil to lymphocyte ratio improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents".
    Uz B
    Ann Hematol; 2016 Feb; 95(3):521-2. PubMed ID: 26747295
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma.
    Zhou X; Wang J; Xia J; Cheng F; Mao J; Zhu J; Guo H
    Cancer Biomark; 2018; 22(1):43-48. PubMed ID: 29562497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio.
    Kelkitli E; Atay H; Cilingir F; Güler N; Terzi Y; Ozatlı D; Turgut M
    Ann Hematol; 2014 May; 93(5):841-6. PubMed ID: 24337486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma.
    Li Y; Li H; Li W; Wang L; Yan Z; Yao Y; Yao R; Xu K; Li Z
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27925303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratios in Elderly Patients with Multiple Myeloma.
    Wang J; Wang J; Sun C; Xia J; Zhou X; Guo HF
    Clin Lab; 2018 Apr; 64(4):507-513. PubMed ID: 29739072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
    Kuzman JA; Stenehjem DD; Merriman J; Agarwal AM; Patel SB; Hahn AW; Alex A; Albertson D; Gill DM; Agarwal N
    BMC Urol; 2017 Jan; 17(1):1. PubMed ID: 28056941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
    Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
    World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma.
    Yang Y; Liu Z; Wang H
    Med Sci Monit; 2020 Jul; 26():e923716. PubMed ID: 32732863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
    Bila J; Jelicic J; Dencic Fekete M; Trajkovic G; Sretenovic A; Perunicic Jovanovic M; Antic D; Mihaljevic B
    Oncol Res Treat; 2017; 40(10):616-620. PubMed ID: 28950269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.
    Templeton AJ; Knox JJ; Lin X; Simantov R; Xie W; Lawrence N; Broom R; Fay AP; Rini B; Donskov F; Bjarnason GA; Smoragiewicz M; Kollmannsberger C; Kanesvaran R; Alimohamed N; Hermanns T; Wells JC; Amir E; Choueiri TK; Heng DY
    Eur Urol; 2016 Aug; 70(2):358-64. PubMed ID: 26924770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification model in elderly patients with multiple myeloma: clinical role of magnetic resonance imaging combined with international staging system and cytogenetic abnormalities.
    Song MK; Chung JS; Lee JJ; Lee JH; Song IC; Lee SM; Shin DY; Lee GW; Lee IS
    Acta Haematol; 2015; 134(1):7-16. PubMed ID: 25832367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) staging.
    Conway AM; Salih Z; Papaxoinis G; Fletcher K; Weaver J; Patrao A; Noble R; Stamatopoulou S; Owen-Holt V; Mansoor W
    Med Oncol; 2017 Jun; 34(6):116. PubMed ID: 28500616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen.
    Szudy-Szczyrek A; Mlak R; Mielnik M; Szczyrek M; Nowaczyńska A; Homa-Mlak I; Zmorzyński S; Kuśmierczuk K; Sompor J; Filip A; Małecka-Massalska T; Hus M
    Ann Hematol; 2020 Dec; 99(12):2881-2891. PubMed ID: 32458064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.
    Feng Z; Wen H; Bi R; Ju X; Chen X; Yang W; Wu X
    PLoS One; 2016; 11(5):e0156101. PubMed ID: 27203425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of multiple myeloma: a report of 182 cases].
    Xu L; Wang Y; Wu W; Yan H; Gao XD; Yu Q; Shen ZX; Mi JQ
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):972-7. PubMed ID: 20646647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?
    Cetin B; Berk V; Kaplan MA; Afsar B; Tufan G; Ozkan M; Isikdogan A; Benekli M; Coskun U; Buyukberber S
    Clin Genitourin Cancer; 2013 Jun; 11(2):141-8. PubMed ID: 23083797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.